{"nct_id":"NCT00426530","title":"Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer","status":"COMPLETED","status_verified_date":"2016-04","start_date":"2007-02","start_date_type":null,"primary_completion_date":"2010-06","primary_completion_date_type":"ACTUAL","completion_date":"2010-06","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["NVS"]}